Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Aug 08, 2019 9:56pm

104 Views

Post# 30009232

Canl Mackie earns its lucrative commisions?

Yes, and here's how: The deal closes, Mackie starts visibly supporting the stock, but more importantly, issues a strong buy recommendation with a 90-cent PT or 200% upside. Traders will flock to the situation, creating a possible scenario where some traders are converted into long-term investors.

Is 90 cents an incrediculous call? Not on your life. The apparent dark cloud that looms above us now may have not just a SILVER - but a GOLDEN lining.

Bullboard Posts

A Look into the Future of Chronic Pain Management